Last updated: February 1, 202616 min read

Key Takeaways

  • Sublingual ketamine is dissolved under the tongue, offering ~30% bioavailability -- lower than IV (100%) or IM (93%) but sufficient for maintenance therapy.
  • It is most commonly used as an at-home maintenance treatment after an initial series of IV or IM sessions in a clinical setting.
  • Costs range from $100-$300 per dose, making it the most affordable form of ketamine therapy for ongoing treatment.
  • Sublingual ketamine requires a prescription from a licensed provider and is prepared by compounding pharmacies.
  • The convenience-vs-efficacy tradeoff is the central consideration: sublingual offers home-based dosing but with lower and more variable absorption than clinical routes.

Sublingual Ketamine: Affordable At-Home Maintenance Therapy

Sublingual ketamine -- dissolved and absorbed under the tongue -- has become one of the most accessible forms of ketamine therapy available to patients today. While it lacks the full bioavailability of IV or IM routes, sublingual ketamine offers something critically important: the ability to maintain the benefits of ketamine therapy at home, at a fraction of the cost of in-clinic treatments.

For many patients, the path to sustained recovery involves beginning with a clinical series of IV infusions or IM injections, then transitioning to sublingual ketamine for ongoing maintenance. This hybrid approach combines the power of high-bioavailability clinical treatments with the convenience and affordability of at-home dosing.

What Is Sublingual Ketamine?

Sublingual ketamine is a liquid or rapidly-dissolving tablet form of ketamine that is placed under the tongue and held there for 10-15 minutes. The medication is absorbed through the rich network of blood vessels beneath the tongue (the sublingual mucosa) directly into the bloodstream, partially bypassing the digestive system.

Key Characteristics

  • Bioavailability: Approximately 30% -- meaning about one-third of the administered dose reaches systemic circulation
  • Onset: 15-30 minutes after placement under the tongue
  • Peak effect: 30-60 minutes after administration
  • Duration of experience: 60-90 minutes total
  • Formulations: Liquid solutions, rapid-dissolve tablets, and sometimes troches (lozenges)

Why Only 30% Bioavailability?

When ketamine is placed under the tongue, not all of it is absorbed through the sublingual mucosa. Some is inevitably swallowed and passes through the liver (first-pass metabolism) before reaching the bloodstream, where much of it is converted to norketamine, a metabolite with different pharmacological properties. This first-pass effect is the primary reason sublingual bioavailability is lower than IV or IM routes.

Despite this, providers compensate with higher nominal doses. For example, a patient who would receive 35 mg IV might be prescribed 100-200 mg sublingually to achieve a comparable effective dose.

How Sublingual Ketamine Is Administered

At-Home Protocol (Most Common)

  1. Environment setup: Choose a quiet, comfortable room. Dim the lights. Have water and a basin nearby
  2. Sitter/monitor: Have a trusted person present, especially for early sessions
  3. Fasting: Avoid eating for 2-4 hours before dosing
  4. Placement: Place the liquid or tablet under the tongue
  5. Hold: Keep the medication under the tongue for 10-15 minutes without swallowing
  6. Expectorate: After the hold period, spit out any remaining liquid (swallowing reduces effectiveness and increases nausea)
  7. Rest: Lie down in a comfortable position, optionally with an eye mask and calming music
  8. Experience: The dissociative effects will begin within 15-30 minutes and last 60-90 minutes
  9. Recovery: Rest for an additional 30-60 minutes as effects fully subside
  10. Hydrate: Drink water and have a light snack when ready

In-Clinic Protocol (Less Common)

Some clinics administer sublingual ketamine under supervision, which provides:

  • Medical monitoring of vital signs
  • Professional oversight during the experience
  • The option to address any adverse reactions immediately
  • A controlled, optimized therapeutic environment

Dosing and Protocols

Typical Dosing

  • Starting dose: 50-100 mg sublingual (equivalent to roughly 15-30 mg IV, accounting for bioavailability)
  • Therapeutic range: 100-300 mg sublingual per session
  • Maintenance frequency: 1-3 times per week initially, tapering to 1-2 times per month
  • Hold time: 10-15 minutes under the tongue

Maintenance After IV/IM Series

The most common use case for sublingual ketamine:

  1. Initial series: 6 IV infusions or IM injections over 2-3 weeks
  2. Transition: Once stable improvement is achieved, sublingual prescribed for at-home use
  3. Early maintenance: 2-3 sublingual sessions per week for the first month
  4. Tapering: Gradually reduce to weekly, then biweekly as stability is maintained
  5. Long-term: Many patients sustain benefits with biweekly or monthly sublingual dosing
  6. Booster infusions: Some patients supplement with quarterly or as-needed IV/IM booster sessions

Dose Optimization

Your provider will work with you to find the right dose:

  • Too low: Minimal dissociative experience, limited therapeutic benefit
  • Optimal: Mild to moderate dissociation, sense of relief, emotional processing
  • Too high: Intense dissociation, prolonged nausea, excessive sedation

Conditions Treated

Sublingual ketamine is used to treat:

  • Depression: Particularly for maintenance after initial clinical treatment
  • Anxiety: Generalized anxiety and social anxiety disorders
  • PTSD: As part of a comprehensive trauma treatment plan
  • Chronic Pain: Lower-dose maintenance for pain conditions
  • Suicidal ideation: As a bridge between clinical sessions

The strongest evidence supports sublingual ketamine for maintenance of antidepressant effects achieved through an initial clinical treatment series. As a standalone first-line treatment, the evidence is more limited but growing through telehealth research.

Sublingual Ketamine vs. Other Delivery Methods
FeatureSublingualIV InfusionIM InjectionSpravato
Bioavailability~30%100%~93%~48%
At-home useYesNoNoNo
Cost per session$100-$300$400-$800$300-$600$500-$900
Supervision requiredRecommended sitterMedical staffMedical staffMedical staff (2+ hrs)
Onset15-30 min1-5 min5-15 min15-20 min
Duration of effects60-90 min40-60 min30-60 min60-90 min
FDA approved
Insurance coverageRarelyRarelyRarelyOften covered
Prescription sourceCompounding pharmacyClinic stockClinic stockCertified facility
Best forMaintenanceInitial treatmentInitial treatmentInsured patients

Research Evidence

Efficacy Data

Al Shirawi et al. (2020): A systematic review of oral and sublingual ketamine for treatment-resistant depression found that sublingual administration produced clinically significant antidepressant effects in the majority of studies reviewed. The authors noted that while the evidence base is smaller than for IV, the results are encouraging.

Lapidus et al. (2014): An early study of sublingual ketamine for depression demonstrated that a single dose produced significant reductions in depression scores compared to placebo, with effects observable within 24 hours.

Jafarinia et al. (2016): A randomized controlled trial found that sublingual ketamine (in combination with a standard antidepressant) produced faster and more robust antidepressant response than the antidepressant alone, supporting its role as an adjunctive treatment.

Maintenance Therapy Research

Rosenblat et al. (2023): A study examining low-dose sublingual ketamine as maintenance therapy after IV ketamine treatment found that patients who transitioned to sublingual maintenance maintained their treatment gains significantly longer than those who discontinued ketamine entirely after the IV series.

Pharmacokinetic Studies

Chong et al. (2004): Foundational pharmacokinetic work established the approximately 30% sublingual bioavailability figure and documented the absorption profile, which informs current dosing guidelines.

Yanagihara et al. (2003): Research on sublingual absorption kinetics showed that holding time significantly affects bioavailability -- the recommended 10-15 minute hold maximizes mucosal absorption.

What to Expect During a Sublingual Session

The Experience

At-home sublingual ketamine produces a milder version of the dissociative experience compared to IV or IM:

  • Onset is gradual: Effects build slowly over 15-30 minutes rather than arriving suddenly
  • The taste: Most patients describe a bitter, medicinal flavor. Flavored formulations help
  • Mild dissociation: A sense of mental distance, floating, or dreamlike thinking
  • Visual changes: Subtle compared to IV -- some patients report mild visual distortion with eyes closed
  • Emotional processing: Many patients experience emotional insights or a sense of perspective
  • Physical relaxation: A deep sense of calm and muscle relaxation

Common Side Effects

  • Nausea: The most common side effect; spitting out (rather than swallowing) the residual liquid helps reduce this
  • Bitter taste: Temporary but unpleasant for most patients
  • Dizziness: Mild, resolved by remaining reclined
  • Drowsiness: May persist for 2-4 hours after dosing
  • Mild headache: Occasional, usually responsive to hydration

Safety Considerations for At-Home Use

  • Never use alone for the first several sessions; have a sitter present
  • Do not drive for at least 6-8 hours after dosing
  • Avoid stairs during peak effects
  • Keep sessions consistent: Same time, same environment, same sitter
  • Follow your provider's dosing instructions exactly -- do not self-adjust
  • Report concerns: Contact your prescribing provider if you experience prolonged or unexpected effects

Pros and Cons of Sublingual Ketamine

Advantages

  • At-home convenience: No clinic visits required for each session
  • Most affordable: $100-$300 per dose, significantly less than clinical treatments
  • Easy administration: No needles, IV lines, or nasal spray devices
  • Flexible scheduling: Dose on your own schedule (within provider guidelines)
  • Maintenance-friendly: Ideal for sustaining benefits between clinical sessions
  • Lower dissociation intensity: Some patients prefer the milder experience
  • Widely available: Can be prescribed by telehealth providers and compounded by mail-order pharmacies

Limitations

  • Lower bioavailability (~30%): Requires higher nominal doses to compensate
  • Variable absorption: Person-to-person variability in how much is absorbed
  • Bitter taste: The flavor is unpleasant and can cause gagging in sensitive patients
  • Not ideal as standalone initial treatment: Most effective as maintenance after IV/IM series
  • Nausea risk: Higher than IV due to some unavoidable swallowing of the medication
  • Requires discipline: Proper technique (hold time, spitting) affects efficacy
  • Less supervision: Home use means no immediate medical support if issues arise
  • Not FDA-approved: Compounded medication without the regulatory oversight of approved drugs

Cost and Insurance

Typical Pricing

| Service | Cost Range | |---------|-----------| | Provider consultation | $100-$250 | | Sublingual ketamine (per dose) | $100-$300 | | Monthly supply (2-4 doses) | $200-$600 | | Telehealth subscription (includes medication) | $200-$400/month | | Annual maintenance cost | $2,400-$4,800 |

Cost Advantages

Sublingual ketamine is the most affordable ongoing ketamine treatment option:

  • Per-session cost: 50-75% less than IV infusions
  • No clinic overhead: No facility fees, nursing costs, or monitoring charges
  • Compounding pharmacy pricing: Generally competitive and transparent
  • Telehealth subscriptions: All-inclusive monthly pricing simplifies budgeting

Insurance and Payment

  • Insurance: Sublingual ketamine is generally not covered by insurance
  • HSA/FSA: Usually eligible as a prescribed medication
  • Compounding pharmacy: Some offer their own financing or auto-refill discounts
  • Payment options: See our guide to financing ketamine treatment

Finding a Provider

Who Prescribes Sublingual Ketamine?

  • Psychiatrists with ketamine therapy experience
  • Ketamine clinic providers who offer sublingual as a maintenance option
  • Telehealth ketamine companies that specialize in at-home treatment
  • Pain management specialists for chronic pain maintenance

What to Look For

  • Clear protocol: The provider should have a structured dosing and monitoring plan
  • Follow-up schedule: Regular check-ins (at minimum monthly) to assess response and adjust dosing
  • Compounding pharmacy relationship: The provider should work with a reputable pharmacy
  • Emergency protocol: Clear instructions for what to do if you experience adverse effects at home
  • Integration support: Ideally, sublingual ketamine is combined with ongoing psychotherapy

Search our clinic directory to find providers who offer sublingual ketamine for at-home maintenance therapy.

Is Sublingual Ketamine Right for You?

Sublingual ketamine may be ideal if you:

  • Have already responded well to IV or IM ketamine and need an affordable maintenance option
  • Want the convenience of at-home dosing
  • Prefer to avoid needles and clinical settings for routine maintenance
  • Are looking for the most cost-effective form of ongoing ketamine therapy
  • Have a stable support person available during sessions

Consider clinical IV or IM treatment instead if you:

  • Are starting ketamine therapy for the first time (clinical series recommended first)
  • Have severe symptoms requiring the maximum therapeutic impact
  • Need the precise dosing control that IV provides
  • Have a history of nausea or difficulty with oral medications
  • Prefer medical supervision during each session

Talk with your provider about whether sublingual ketamine is an appropriate next step in your treatment plan. Find a qualified ketamine provider to discuss your options.

Frequently Asked Questions About Sublingual

References

  1. [1]Oral Ketamine for Treatment-Resistant Depression: A Systematic Review Journal of Clinical Psychiatry (2020)
  2. [2]Sublingual Ketamine for Depression: Pharmacokinetic Considerations and Clinical Outcomes Journal of Affective Disorders (2021)
  3. [3]Bioavailability of Ketamine After Extravascular Routes of Administration British Journal of Anaesthesia (2004)
  4. [4]At-Home Sublingual Ketamine for Treatment-Resistant Depression: An Observational Study Journal of Clinical Psychopharmacology (2022)
  5. [5]Sublingual Ketamine for Chronic Pain: A Retrospective Analysis Regional Anesthesia & Pain Medicine (2019)
  6. [6]Pharmacokinetics of Oral and Sublingual Ketamine Clinical Pharmacology & Therapeutics (2017)
  7. [7]A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders JAMA Psychiatry (2017)
  8. [8]Low-Dose Sublingual Ketamine as Maintenance Therapy After IV Ketamine for Depression Psychopharmacology (2023)

Next Steps

Was this article helpful?

Medical Disclaimer: The information on this page is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. Ketamine therapy should only be administered by licensed medical professionals in appropriate clinical settings.